Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
FGFR3 Gene Fusion/Rearrangement
Boston, Massachusetts
FGFR3 Gene Fusion/Rearrangement Clinical Trials in Boston, Massachusetts
1 recruiting
Boston, Massachusetts
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors
Cholangiocarcinoma
Advanced Solid Tumors
Intrahepatic Cholangiocarcinoma (Icc)
+9 more
Cogent Biosciences, Inc.
110 enrolled
15 locations
NCT06777316
Feedback